These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 5501425)

  • 1. [Significance of the liver for the biological activity of drugs].
    Ackermann E
    Dtsch Z Verdau Stoffwechselkr; 1970; 30(1):3-8. PubMed ID: 5501425
    [No Abstract]   [Full Text] [Related]  

  • 2. [Aminophenazone half life in patients with chronic liver parenchyma disorders].
    Ackermann E; Renger F; Dökert B; Walther M
    Z Gesamte Inn Med; 1972 Oct; 27(19):849-53. PubMed ID: 4647370
    [No Abstract]   [Full Text] [Related]  

  • 3. Microsomal electron transport reactions. II. The use of reduced triphosphopyridine nucleotide and-or reduced diphosphopyridine nucleotide for the oxidative N-demethylation of aminopyrine and other drug substrates.
    Cohen BS; Estabrook RW
    Arch Biochem Biophys; 1971 Mar; 143(1):46-53. PubMed ID: 4397837
    [No Abstract]   [Full Text] [Related]  

  • 4. Nickel carbonyl inhibition of induction of aminopyrine demethylase activity in liver and lung.
    Sunderman FW; Leibman KC
    Cancer Res; 1970 Jun; 30(6):1645-50. PubMed ID: 5457934
    [No Abstract]   [Full Text] [Related]  

  • 5. [Pharmacokinetics in chronic hepatopathies. Studies on an aminophenazone model].
    Wagner K; Schneider G; Leutke D; Schimmelpfennig W; Theuer D; Heinemann L
    Dtsch Gesundheitsw; 1970 Jun; 25(24):1109-14. PubMed ID: 5508902
    [No Abstract]   [Full Text] [Related]  

  • 6. [Chemical structure of the endoplasmic reticulum and function of the microsomal biotransformation system of liver cells in experimental cholestasis in the rat].
    Denk H
    Pathol Eur; 1972; 7(1):43-65. PubMed ID: 5054568
    [No Abstract]   [Full Text] [Related]  

  • 7. Oxidative drug metabolism in human liver microsomes.
    Nelson EB; Raj PP; Belfi KJ; Masters BS
    J Pharmacol Exp Ther; 1971 Sep; 178(3):580-8. PubMed ID: 4398379
    [No Abstract]   [Full Text] [Related]  

  • 8. [Demethylation of aminophenazone and codeine in human liver. An investigation of microsomal electron transport].
    Ackermann E
    Biochem Pharmacol; 1970 Jun; 19(6):1955-73. PubMed ID: 4398024
    [No Abstract]   [Full Text] [Related]  

  • 9. Hepatic microsomal enzymes and their alterations in pathologic conditions.
    Denk H
    Prog Liver Dis; 1979; 6():263-83. PubMed ID: 396559
    [No Abstract]   [Full Text] [Related]  

  • 10. [Phenazon metabolism in children with liver diseases].
    Orzechowska-Juzwenko K; Rabenda C; Wiela-Hojeńska A; Kubicz Z; Saraczyńska E; Rudkowski Z; Drabik E
    Pol Tyg Lek; 1992 Mar 16-30; 47(11-13):265-7. PubMed ID: 1437728
    [No Abstract]   [Full Text] [Related]  

  • 11. The determination of aminopyrin elimination for control of the metabolic capacity of the liver in man.
    Haustein KO; Hüller G; Sensing H
    Eur J Clin Invest; 1982 Apr; 12(2):157-64. PubMed ID: 6807687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Syndnones as inhibitors of biotransformation].
    Ackermann E
    Acta Biol Med Ger; 1966; 17(4):498-506. PubMed ID: 5983632
    [No Abstract]   [Full Text] [Related]  

  • 13. [Extramitochondrial oxidative systems].
    Rubin BA; Loginova LN
    Usp Sovrem Biol; 1971; 72(2):253-72. PubMed ID: 4336477
    [No Abstract]   [Full Text] [Related]  

  • 14. Hepatic organelle interaction. I. Spectral investigation during drug biotransformation.
    Cinti DL; Schenkman JB
    Mol Pharmacol; 1972 May; 8(3):327-38. PubMed ID: 4402749
    [No Abstract]   [Full Text] [Related]  

  • 15. [Altered biotransformation of phenazone, aminophenazone and codeine as evidence of early injury to rat liver after administration of carbon tetrachloride].
    Klinger W; Neugebauer A; Splinter FK
    Arch Toxikol; 1968; 23(3):178-85. PubMed ID: 5704785
    [No Abstract]   [Full Text] [Related]  

  • 16. DPNH synergism of TPNH-dependent mixed function oxidase reactions.
    Correia MA; Mannering GJ
    Drug Metab Dispos; 1973; 1(1):139-49. PubMed ID: 4149375
    [No Abstract]   [Full Text] [Related]  

  • 17. [Inactivation of estradiol by oxidation following liver damage in rats and in patients with liver diseases].
    Wenzel M; Blum KU; Kraas E
    Z Klin Chem Klin Biochem; 1968 Jun; 6(4):265-8. PubMed ID: 5728049
    [No Abstract]   [Full Text] [Related]  

  • 18. Metabolic action of urethan on protein synthesis and drug oxidation in normal and regenerating liver.
    Glazer RI; Cinti DL; Murahata RI; Schenkman JB; Sartorelli AC
    Biochem Pharmacol; 1972 Nov; 21(21):2867-75. PubMed ID: 4345861
    [No Abstract]   [Full Text] [Related]  

  • 19. Further studies on the metabolism of drugs by subfractions of hepatic microsomes.
    Gram TE; Rogers LA; Fouts JR
    J Pharmacol Exp Ther; 1967 Mar; 155(3):479-93. PubMed ID: 6022622
    [No Abstract]   [Full Text] [Related]  

  • 20. The metabolism of drugs by hepatic microsomal enzymes. Studies on intramicrosomal distribution of enzymes and relationships between enzyme activity and structure of the hepatic endoplasmic reticulum.
    Fouts JR; Rogers LA; Gram TE
    Exp Mol Pathol; 1966 Oct; 5(5):475-90. PubMed ID: 5920448
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.